Kevin G. Lafond's most recent trade in Alaunos Therapeutics Inc was a trade of 18,020 Common Stock done at an average price of $3.1 . Disclosure was reported to the exchange on Jan. 8, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alaunos Therapeutics Inc | Kevin G. Lafond | SVP, Treasurer & CAO | Sale of securities on an exchange or to another person at price $ 3.09 per share. | 08 Jan 2021 | 18,020 | 63,965 (0%) | 0% | 3.1 | 55,682 | Common Stock |